Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "pulmonary" wg kryterium: Temat


Wyświetlanie 1-6 z 6
Tytuł:
A patient with lung cancer and increased right ventricular pressure – should all lung cancer patients be suspected of pulmonary embolism?
Autorzy:
Styczkiewicz, Katarzyna
Mędrek, Sabina
Adamowicz, Adam
Styczkiewicz, Marek
Powiązania:
https://bibliotekanauki.pl/articles/1035688.pdf
Data publikacji:
2019
Wydawca:
Medical Education
Tematy:
lung cancer
pulmonary embolism
pulmonary hypertension
right ventricle pressure
Opis:
Lung cancer is associated with an increased risk of venous thromboembolism, including pulmonary embolism. In some situations, clinical deterioration in patients with lung cancer accompanied by elevated pressure in the right ventricle, usually measured by commonly used echocardiography, may support the diagnosis of pulmonary embolism. However, there are many other causes of increased pressure in the right ventricle in such patients, for example: progression of cancer, pre-existing lung diseases, surgical resection of pulmonary tissue, pnemotoxicity of radiotherapy or concomitant diseases of the left heart. The article presents 2 clinical cases of patients with lung cancer, in which elevated pressure in the right ventricle was resulted from other causes and accompanied the progression of cancer, despite the clinical picture suggesting a pulmonary embolism. Increased pressure in the right ventricle and usually associated pulmonary hypertension, significantly worsen already poor prognosis of patients with lung cancer. The differential diagnosis should, therefore, take into account the whole clinical picture, excluding venous thromboembolism as an important cause of pulmonary hypertension, but also take into account other potential factors to be able to make the right diagnosis and implement optimal treatment as early as possible.
Źródło:
OncoReview; 2019, 9, 2; 45-50
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Idiopathic venous thromboembolism or occult cancer?
Autorzy:
Darocha, Szymon
Florczyk, Michał
Torbicki, Adam
Powiązania:
https://bibliotekanauki.pl/articles/1065841.pdf
Data publikacji:
2014
Wydawca:
Medical Education
Tematy:
pulmonary embolism
screening for occult cancer
venous thromboembolism
Opis:
The relationship between cancer and an increased incidence of venous thromboembolism (VTE) is well documented. VTE is a common complication of cancer, which usually occurs in the advanced stages of the disease. It often manifests itself before the cancer has been diagnosed and frequently is the first symptom of malignancy. In particular, pulmonary embolism is a major epidemiological problem because of its prevalence and high mortality. This article contains a review of the literature on VTE and occult cancer. It indicates the problem of a lack of an effective diagnostic strategy for malignancy in patients with idiopathic venous thromboembolism.
Źródło:
OncoReview; 2014, 4, 1; A5-10
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Recurrent pulmonary embolism in a patient with renal tumor
Autorzy:
Kępski, Jarosław
Kurzyna, Marcin
Szmit, Sebastian
Powiązania:
https://bibliotekanauki.pl/articles/1062547.pdf
Data publikacji:
2017
Wydawca:
Medical Education
Tematy:
clear cell carcinoma
heparin
pulmonary embolism
renal tumor
thrombosis
vena cava filter
Opis:
Venous thromboembolism is one of the main causes of sudden death in hospitalized patients. Among the classical risk factors involved, cancer occupies a special place. Up to 20% of oncological patients will develop a VTE episode, and in 10% of them, it will be a direct cause of death. In the case presented below, incidental pulmonary embolism and renal tumor were diagnosed at the same time, and there was an event of embolism despite optimal antithrombotic treatment. Such a scenario of complications may correlate with a clinically advanced stage of cancer, and may be associated with a poorer prognosis, requiring an individualized therapeutic management.
Źródło:
OncoReview; 2017, 7, 4; 171-175
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Recurrent invasive pulmonary aspergillosis or breakthrough fungal infection in a child after haploidentical hematopoietic stem cell transplantation
Autorzy:
Ociepa, Tomasz
Powiązania:
https://bibliotekanauki.pl/articles/1064850.pdf
Data publikacji:
2016
Wydawca:
Medical Education
Tematy:
breakthrough infection
children
hematopoietic stem cell transplantation
invasive fungal infection
invasive pulmonary aspergillosis
Opis:
Invasive fungal infections (IFI) are devastating and life-threatening infections affecting especially immunocompromised patients. We report on a case of a 14-year-old boy with myelodysplastic syndrome (MDS), after haploidentical hematopoietic stem cell transplantation, in whom invasive pulmonary aspergillosis (IA) was diagnosed and successfully treated with subsequent (despite the secondary antifungal prophylaxis) IA or breakthrough infection development. Thanks to intensive and broad spectrum antifungal treatment (voriconazole upfront therapy, followed by a combination of voriconazole and micafungin, and eventually by the amphotericin B lipid complex), significant improvement was accomplished.
Źródło:
OncoReview; 2016, 6, 3; A122-127
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Invasive pulmonary aspergillosis in a child with acute myeloid leukaemia: pharmacotherapy and surgical management
Autorzy:
Styczyński, Jan
Powiązania:
https://bibliotekanauki.pl/articles/1064789.pdf
Data publikacji:
2016
Wydawca:
Medical Education
Tematy:
amphotericin B lipid form
chemotherapy
haematopoietic stem cell transplantation
invasive fungal disease
invasive fungal infection
pulmonary aspergillosis
Opis:
This paper reports on diagnostic and therapeutic management of pulmonary invasive fungal disease (IFD) in a child with relapsed acute myeloid leukaemia, undergoing chemotherapy followed by haematopoietic stem cell transplantation. Surgical management with resection of the involved lung tissue was based on the location of fungal infiltrates close to large circulatory vessels. After examination of resected pulmonary tissue, a diagnosis of proven IFD was done. This case report is an example that aspergillosis is usually the cause for pulmonary IFD. Pharmacotherapy of pulmonary IFD should be based on compounds with good penetration to lung tissue: amphotericin B lipid form or voriconazole.
Źródło:
OncoReview; 2016, 6, 4; A169-174
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Pneumonia in patients after hematopoietic stem cell transplantation
Autorzy:
Styczyński, Jan
Powiązania:
https://bibliotekanauki.pl/articles/1062942.pdf
Data publikacji:
2017
Wydawca:
Medical Education
Tematy:
amphotericin B lipid complex
chemotherapy
hematopoietic stem cell transplantation
invasive fungal disease
invasive fungal infection
pneumonia
pulmonary aspergillosis
Opis:
Pneumonia is one of the most frequent cause of death after hematopoietic stem cell transplantation (HSCT). The objective of this review is to present various aspects of pneumonia in this group of patients, with focus on invasive pulmonary aspergillosis and cytomegalovirus disease, being the most frequent etiological causes of pneumonia after HSCT. The review is aimed at practical approach to diagnostic and therapeutic management of pneumonia after HSCT with special attention to: definitions of infections and level of diagnosis of upper and lower respiratory tract infections, including issues specific for invasive fungal disease, pneumocystosis, cytomegalovirus disease, community acquired respiratory viral infections and bacterial pneumonia. Another topics analyzed in the review are: epidemiology and risk factors for development of infection and risk of death due to pneumonia; invasive and non-invasive diagnostics, including imaging and laboratory biomarkers; methods of pharmacological and environmental prophylaxis and specific targeted therapy of pneumonia after HSCT.
Źródło:
OncoReview; 2017, 7, 3; 126-138
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies